February 2022
Latest issue
Volume 12, Issue 2
2.1 weeks
Time to First Decision
3.7 weeks
Review Time
1.5 weeks
Publication Time
12%
Acceptance Rate
Editor-in-Chief
View full Editorial BoardArticles
https://doi.org/10.1016/j.apsb.2022.03.002
https://doi.org/10.1016/j.apsb.2022.02.031
https://doi.org/10.1016/j.apsb.2022.02.029
https://doi.org/10.1016/j.apsb.2022.02.030
https://doi.org/10.1016/j.apsb.2022.02.032
https://doi.org/10.1016/j.apsb.2022.02.028
https://doi.org/10.1016/j.apsb.2022.02.025
https://doi.org/10.1016/j.apsb.2022.02.023
More from Acta Pharmaceutica Sinica B
27 July 2017
Special Issue — Targeted Cancer Therapy
Article collections
2211-3835
ISSN
Copyright © 2022 Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association. Production and hosting by Elsevier B.V. All rights reserved